Back to Search
MALLINATH HADIMANI, PHD, RPH
PHD, RPH
Pharmacist
NPI: 1457641797Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
20916(NC)
Research & Publications (7)
Inhibitors of RecA activity discovered by high-throughput screening: cell-permeable small molecules attenuate the SOS response in Escherichia coli.
PMID 19675313·J Biomol Screen·2009
8-other
Development of synthetic methodology suitable for the radiosynthesis of combretastatin A-1 (CA1) and its corresponding prodrug CA1P.
PMID 19161336·J Nat Prod·2009
7-preclinical
Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
PMID 18710804·Bioorg Med Chem Lett·2008
8-other
Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
PMID 18303849·J Nat Prod·2008
7-preclinical
Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.
PMID 16442292·Bioorg Med Chem·2006
7-preclinical
Synthesis, in vitro, and in vivo evaluation of phosphate ester derivatives of combretastatin A-4.
PMID 12699742·Bioorg Med Chem Lett·2003
4-observational
2-(3-tert-Butyldimethylsiloxy-4-methoxyphenyl)-6-methoxy-3-(3,4,5-trimethoxybenzoyl)indole.
PMID 12050432·Acta Crystallogr C·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 370 E MAIN ST STE 160
CARRBORO, NC 27510 - Phone
- (919) 240-7305
Quick Facts
- NPI
- 1457641797
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile